Published Date: 02 Mar 2023
High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer
2.
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer
3.
Patient Endured 9 Years of Chemotherapy for Cancer He Never Had
4.
AI can identify women at risk of breast cancer years in advance: Study
5.
O. A. J. Simpson passes away from cancer.
1.
Survivorship Planning Beyond Active Cancer Care
2.
Individualized Hematopoietic Reserve Assessment in Blood Disorders
3.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
4.
Practical Concepts in Hematology and Patient Outcomes
5.
The Miracle of Tenecteplase: How This Drug Is Saving Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation